HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 497,200 Value ($000) $33,462 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 393,755 Value ($000) $28,878 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 389,131 Value ($000) $20,243 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 463,608 Value ($000) $29,583 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 4,426 Value ($000) $212 Avg Close $51.28 Range $42.01 - $62.13
Q1 2024
Shares 75,533 Value ($000) $3,073 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 646,168 Value ($000) $23,882 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 2,724,811 Value ($000) $104,088 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 2,323,523 Value ($000) $83,809 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 889,667 Value ($000) $33,976 Avg Close $46.91 Range $32.83 - $57.00
Q2 2022
Shares 110,861 Value ($000) $4,878 Avg Close $43.25 Range $36.95 - $48.58
Q4 2019
Shares 8,317 Value ($000) $147 Avg Close $17.32 Range $14.61 - $19.73
Q2 2019
Shares 513,083 Value ($000) $8,815 Avg Close $16.14 Range $14.65 - $17.43
Q1 2019
Shares 45,947 Value ($000) $740 Avg Close $16.20 Range $13.84 - $17.76